Long-Term Prediction of Severe Hypoglycemia in Type 1 Diabetes: Is It Really Possible?

J Diabetes Sci Technol. 2016 Nov 1;10(6):1230-1235. doi: 10.1177/1932296816664745. Print 2016 Nov.

Abstract

Background: Prediction of risk of severe hypoglycemia (SH) in patients with type 1 diabetes is important to prevent future episodes, but it is unknown if it is possible to predict the long-term risk of SH. The aim of the study is to assess if long-term prediction of SH is possible in type 1 diabetes.

Methods: A follow-up study was performed with 98 patients with type 1 diabetes. At baseline and at follow-up, the patients filled in a questionnaire about diabetes history and complications, number of SH in the preceding year and state of awareness, and HbA1c and C-peptide levels were measured.

Results: During the 12 years of follow-up, there was a decrease in HbA1c, C-peptide levels, and incidence of SH (1.1 to 0.4 episodes per patient-year; P < .001). At baseline, the relative rate of SH was 3.6 (P = .001) and 10.9 (P < .0001) in patients with impaired awareness and unawareness of hypoglycemia, respectively, as compared to patients with normal awareness. At follow-up, patients with unawareness at baseline tended to have maintained an increased rate of SH (RR = 3.1; P = .07). Impaired awareness, HbA1c and C-peptide determined at baseline did not correspond with an increased rate of SH at follow-up.

Conclusions: Long-term prediction of severe hypoglycemia in type 1 diabetes was not possible, although baseline hypoglycemia unawareness tended to remain a predictor for risk of SH at follow-up. Therefore, it is important repeatedly to assess the different risk factors of SH to determine the actual risk.

Keywords: hypoglycemia awareness; prediction; severe hypoglycemia; type 1 diabetes.

Publication types

  • Historical Article

MeSH terms

  • Adult
  • Aged
  • C-Peptide / analysis*
  • Cross-Sectional Studies
  • Diabetes Complications / epidemiology*
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetes Mellitus, Type 1 / drug therapy
  • Female
  • Follow-Up Studies
  • Glycated Hemoglobin / analysis*
  • History, 17th Century
  • Humans
  • Hypoglycemia / epidemiology*
  • Hypoglycemic Agents / therapeutic use
  • Incidence
  • Insulin / therapeutic use
  • Male
  • Middle Aged
  • Risk Factors

Substances

  • C-Peptide
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • hemoglobin A1c protein, human